Next Article in Journal
TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model
Next Article in Special Issue
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies
Previous Article in Journal
Multiple Perspectives Reveal the Role of DNA Damage Repair Genes in the Molecular Classification and Prognosis of Pancreatic Adenocarcinoma
Previous Article in Special Issue
Modified Polymer Surfaces: Thin Films of Silicate Composites via Polycaprolactone Melt Fusion
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140

Vifor Pharma Management Ltd., Flughofstrasse 61, CH-8152 Glattbrugg, Switzerland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(18), 10230; https://doi.org/10.3390/ijms231810230
Submission received: 22 August 2022 / Accepted: 23 August 2022 / Published: 6 September 2022
The authors wish to make the following corrections to this paper [1]:
In the original publication, there were wrong reference citations in paragraph 7 of Section 2.2 and Table 4 as published.
In Section 2.2, paragraph 7, “Ferumoxytol contains 30 mg of iron/mL. The complex is an iron oxide coated with polyglucose sorbitol carboxymethylether. The chemical formula of ferumoxytol is Fe5874O8752-C11719H18682O9933Na414 [24]” should be replaced with “Ferumoxytol contains 30 mg of iron/mL. The complex is an iron oxide coated with polyglucose sorbitol carboxymethylether [25]. The chemical formula of ferumoxytol is Fe5874O8752-C11719H18682O9933Na414 [26]”.
In Table 4, the reference numbers did not correspond with the correct numbers in the reference list. The corrected Table 4 appears below:
ProductMolecular Weight (kDa)Particle Size (nm)[39]Zeta Potential (mV)[39]Crystalline StructureReduction Potential (mV) °[25]Reduction Kinetics k(Θ) × 103 (min−1)
Θ = 0.1/0.5/0.8[25]
Blocking Temperature (K)
[25,40]
Iron sucrose34–60 [17,41]
42–44 [25]
252 [42]
140 [39]
8.3 (PDI 0.192)pH 7.43: −26.20
pH 11.03 *: −28.15
2-line ferrihydrite [39]
Ferrihydrite and lepidocrocite [41]
Akageneite [33]
2-line ferrihydrite-like [40]
No clear identification [25]
−494107/89/117 §55
Sodium ferric gluconate289–440 [18]
37.5 [9]
200 [42]
164 [39]
8.6 (PDI 0.244)pH 7.4: −29.70
pH 8.36 *: −29.10
2-line ferrihydrite ([39]
Ferrihydrite and lepidocrocite [41]
Akaganeite [33]
ndndnd
Iron dextran165 [20]
165 [39]
12.2 (PDI 0.149)pH 6.4 *: −15.30
pH 7.31: −17.25
Akageneite [39,41]ndndnd
Ferric derisomaltose155[22]
63–69 [25]
150 [39]
9.9 (PDI 0.182)pH 6.3 *: −22.0
pH 7.35: −21.05
Akaganeite [25,39,41]−338/−50821/41/6356
Ferric carboxymaltose≈ 150 [24]
145–155 [25]
233 [39]
23.1 (PDI 0.07)pH 5.36: 3.68
pH 7.26: −8.52
Akaganeite [25,39,41]−33318/35/55114
Ferumoxytol750 [26]
172–188 [25]
731 [42]
276 [39]
23.6 (PDI 0.143)pH 6.6: −43.20
pH 7.36: −30.55
Magnetite/Maghemite [39]
Magnetite [41]
Maghemite [25]
−245/−76836/67/9873
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Funk, F.; Flühmann, B.; Barton, A.E. Criticality of surface characteristics of intravenous iron-carbohydrate nanoparticle complexes: Implications for pharmacokinetics and pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Funk, F.; Flühmann, B.; Barton, A.E. Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140. Int. J. Mol. Sci. 2022, 23, 10230. https://doi.org/10.3390/ijms231810230

AMA Style

Funk F, Flühmann B, Barton AE. Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140. International Journal of Molecular Sciences. 2022; 23(18):10230. https://doi.org/10.3390/ijms231810230

Chicago/Turabian Style

Funk, Felix, Beat Flühmann, and Amy E. Barton. 2022. "Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140" International Journal of Molecular Sciences 23, no. 18: 10230. https://doi.org/10.3390/ijms231810230

APA Style

Funk, F., Flühmann, B., & Barton, A. E. (2022). Correction: Funk et al. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics. Int. J. Mol. Sci. 2022, 23, 2140. International Journal of Molecular Sciences, 23(18), 10230. https://doi.org/10.3390/ijms231810230

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop